About Us
We are building the future of regenerative biologics.
A biotechnology platform transforming autologous biology into personalized regenerative solutions.
FOUNDER
Dr. Fu-Shih Pan, MD., Ph.D.
Founder of Lotusbio
- Physician Scientist in Regenerative Biotechnology
- Bridging clinical medicine and regenerative biology through translational science.
Overview
Dr. Fu-Shih Pan is a physician-scientist whose work bridges clinical medicine, chemistry, and regenerative biotechnology.
Trained at the University of Chicago (MD, Ph.D. in Chemistry) and clinically educated in plastic and reconstructive surgery at the University of Pennsylvania, his career integrates scientific research with surgical and translational medical practice.
His focus lies in understanding how systemic biological environments regulate aging and regenerative capacity, forming the foundation of Lotusbio’s platform technologies.
Research Focus
- Heterochronic Parabiosis
- Stem cell biology and regenerative systems
- Epigenetic regulation of aging
- Systemic factors influencing tissue regeneration
From Science to Platform
Dr. Pan’s work has evolved from foundational biological research into applied regenerative technologies, including PX-100 and the APAA platform developed within Lotusbio.
These innovations aim to translate systemic biological insights into clinically applicable regenerative solutions.
Timeline
Early Academic Foundation
Completed dual doctoral training in Medicine and Chemistry at the University of Chicago, establishing a strong interdisciplinary foundation in biomedical science.
Clinical Training Phase
Trained in plastic and reconstructive surgery at the University of Pennsylvania, with a focus on craniofacial reconstruction and complex tissue repair.
Regenerative Research Phase
Focused research on heterochronic parabiosis, stem cell systems, and epigenetic mechanisms of aging, exploring how systemic biology influences regeneration.
Translational Innovation Phase
Developed translational concepts such as PX-100 and regenerative signaling models that bridge biological theory and applied medicine.
Lotusbio Foundation
Founded Lotusbio to integrate regenerative biology research into a scalable biotechnology platform, focusing on personalized regenerative biologics and APAA technology.
Key Contributions
- Heterochronic parabiosis research advancement
- Development of regenerative signaling concepts
- PX-100 translational technology framework
- APAA platform integration in regenerative biology
- Expansion of personalized regenerative medicine applications
Vision Statement
His work contributes to a future where aging is understood as a modifiable biological process, and regenerative capacity can be systematically activated.